4I JECFA. Summary of Evaluations Performed by the Joint FAO/WHO Expert Committee on Food Additive[EB/OL]. http: //www.inchem. org/documents/jecfa/jeceval/jec_ 1702.htm.
5赫捷,陈万青.2012中国肿瘤登记年报[M].北京:军事医学科学出版社,2012:12-25.
6Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 vl.0, cancer incidence and mortality worldwide: IARC cancerbase No. 11 [EB/OL]. Lyon: International A- gency for Research on Cancer press, 2013. http://globo- can.iarc.fr/Defauh.aspx.
7Ferlay J, Bray F, Steliarova-Foucher E. Cancer incidence in five conti nents, CI5plus. IARC cancerbase No. 9[EB/ OL]. Lyon: International Agency for Research on Cancer press, 2014. http://ci5.iarc.fr/CI5plus/Defauh.aspx.
8Park JY, von Karsa L, Herrero R. Prevention strategies for gastric cancer: a global perspective[J]. Clin Endosc, 2014, 47(6): 478-489.
9Center MM, Jemal A, Smith RA, et al. Worldwide varia- tions in colorectal cancer[J]. CA Cancer J Clin, 2009, 59(6): 366-378.
10Bakkelund KE, Nordrum IS, Fossmark R, et al. Gastric carcinomas localized to the cardia[J]. Gastroenterol Res Pract, 2012, 2012: 457831.
